Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulating Direct-to-Consumer Polygenic Risk Scores.

JAMA - 22 Aug 2023

Sherkow Jacob S, Park Jin K, Lu Christine Y

Abstract excerpt

This Viewpoint discusses the possible harms associated with direct-to-consumer polygenic risk scores and advocates for federal regulation.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genome-Wide Association Study
Share to Multifactorial Inheritance
Share to Risk Assessment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Risk Factors

Source

Identifiers

PMID: 37535347
DOI: 10.1001/jama.2023.12262

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulating Direct-to-Consumer Polygenic Risk Scores.PMID 37535347Read ↗

Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.Semantic proximity Read ↗

Taking the risk. A systematic review of ethical reasons and moral arguments in the clinical use of polygenic risk scores.Semantic proximity Read ↗

Ethical, Legal and Social Implications of Polygenic Scores for Multifactorial Disease: A Narrative Review Identifying Concerns About Interpretation and UseSemantic proximity Read ↗

Implementing polygenic risk scores in the clinic.Semantic proximity Read ↗

Risks of presymptomatic direct-to-consumer genetic testing.Semantic proximity Read ↗

Considerations for clinical implementation of polygenic risk scores in diverse US populations.Semantic proximity Read ↗

Polygenic risk scores in the clinic: a systematic review of stakeholders' perspectives, attitudes, and experiences.Semantic proximity Read ↗

Regulating direct-to-consumer genetic tests: what is all the fuss about?Semantic proximity Read ↗

“Are we not going too far?“: Socio-ethical considerations of preimplantation genetic testing using polygenic risk scores according to healthcare professionalsSemantic proximity Read ↗

Direct‐to‐consumer genetic testing: good, bad or benign?Semantic proximity Read ↗

Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility.Semantic proximity Read ↗

Consumer genetics and addiction susceptibility testing-just what the consumer ordered.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.